BriaCell Therapeutics Corp. Annual Weighted Average Number of Shares Outstanding, Basic from 2021 to 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
BriaCell Therapeutics Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2021 to 2024.
  • BriaCell Therapeutics Corp. Weighted Average Number of Shares Outstanding, Basic for the quarter ending October 31, 2024 was 26.6M shares, a 66.7% increase year-over-year.
  • BriaCell Therapeutics Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 16.5M shares, a 5.35% increase from 2023.
  • BriaCell Therapeutics Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 15.6M shares, a 0.81% increase from 2022.
  • BriaCell Therapeutics Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 15.5M shares, a 243% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 16.5M +835K +5.35% Aug 1, 2023 Jul 31, 2024 10-K 2024-10-29
2023 15.6M +126K +0.81% Aug 1, 2022 Jul 31, 2023 10-K 2024-10-29
2022 15.5M +11M +243% Aug 1, 2021 Jul 31, 2022 10-K 2023-10-25
2021 4.52M Aug 1, 2020 Jul 31, 2021 10-K 2022-10-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.